326 related articles for article (PubMed ID: 16973364)
1. Boronic acids as inhibitors of steroid sulfatase.
Ahmed V; Liu Y; Silvestro C; Taylor SD
Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
Phan CM; Liu Y; Kim BM; Mostafa Y; Taylor SD
Bioorg Med Chem; 2011 Oct; 19(20):5999-6005. PubMed ID: 21925885
[TBL] [Abstract][Full Text] [Related]
3. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
4. Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
Schreiner EP; Billich A
Bioorg Med Chem Lett; 2004 Oct; 14(19):4999-5002. PubMed ID: 15341968
[TBL] [Abstract][Full Text] [Related]
5. 2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase.
Horvath A; Nussbaumer P; Wolff B; Billich A
J Med Chem; 2004 Aug; 47(17):4268-76. PubMed ID: 15293998
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
Lawrence Woo LW; Leblond B; Purohit A; Potter BV
Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a non-hydrolyzable estrone sulfate analogue bearing the difluoromethanesulfonamide group and its evaluation as a steroid sulfatase inhibitor.
Liu Y; Ahmed V; Hill B; Taylor SD
Org Biomol Chem; 2005 Sep; 3(18):3329-35. PubMed ID: 16132094
[TBL] [Abstract][Full Text] [Related]
8. The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
Lapierre J; Ahmed V; Chen MJ; Ispahany M; Guillemette JG; Taylor SD
Bioorg Med Chem Lett; 2004 Jan; 14(1):151-5. PubMed ID: 14684318
[TBL] [Abstract][Full Text] [Related]
9. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
10. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
[TBL] [Abstract][Full Text] [Related]
11. Steroid sulfatase inhibitors.
Nussbaumer P; Billich A
Med Res Rev; 2004 Jul; 24(4):529-76. PubMed ID: 15170594
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship for aryl and heteroaryl boronic acid inhibitors of hormone-sensitive lipase.
Ebdrup S; Jacobsen P; Farrington AD; Vedsø P
Bioorg Med Chem; 2005 Mar; 13(6):2305-12. PubMed ID: 15727879
[TBL] [Abstract][Full Text] [Related]
13. Steroid sulfatase: molecular biology, regulation, and inhibition.
Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
[TBL] [Abstract][Full Text] [Related]
15. N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase.
Lehr P; Billich A; Wolff B; Nussbaumer P
Bioorg Med Chem Lett; 2005 Feb; 15(4):1235-8. PubMed ID: 15686949
[TBL] [Abstract][Full Text] [Related]
16. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
[TBL] [Abstract][Full Text] [Related]
18. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
19. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.
Suzuki N; Suzuki T; Ota Y; Nakano T; Kurihara M; Okuda H; Yamori T; Tsumoto H; Nakagawa H; Miyata N
J Med Chem; 2009 May; 52(9):2909-22. PubMed ID: 19419205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
